Gerard Orriols
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gerard Orriols has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alexa Nuñez
Department of Pneumology, Vall d’Hebron Hospital Universitari/Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
1 shared publication Cristina Aljama
Department of Pneumology, Hospital Universitari Vall d´Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
1 shared publicationCristina Esquinas
Department of Pneumology, Hospital Universitari Vall d´Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
1 shared publicationFrancisco Rodriguez-Frias
Department of Clinical Biochemistry, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Department of Basic Sciences, Universitat Internacional de Catalunya, Spain; Clinical Biochemistry Research Group, Valll d'Hebron Institute of Research (VHIR), Spain
1 shared publication- Galo Granados
Pneumology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain
1 shared publication Georgina Farago
Department of Pneumology, Hospital Universitari Vall d´Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
1 shared publication
Latest Publications
- 24 August 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 218, 107394
Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia
- 24 August 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 218, 107394
Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia